MARRIOTT INTERNATIONAL INC /MD/ false 0001048286 0001048286 2021-03-03 2021-03-03





Washington, D.C. 20549







Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 3, 2021




(Exact name of registrant as specified in its charter)




Delaware   1-13881   52-2055918

(State or other jurisdiction
of incorporation)


File Number)


(IRS Employer
Identification No.)


10400 Fernwood Road, Bethesda, Maryland   20817
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (301) 380-3000



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class




Name of each exchange
on which registered

Class A Common Stock, $0.01 par value   MAR   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 8.01. Other Events.

On March 3, 2021, Marriott International, Inc. (“we”) entered into a Terms Agreement with Wells Fargo Securities, LLC, Fifth Third Securities, Inc., J.P. Morgan Securities LLC and the other Underwriters listed on Schedule I thereto (the “Terms Agreement,” which incorporates by reference the Underwriting Agreement General Terms and Provisions, dated March 3, 2021 (the “Underwriting Agreement”)) to issue $1.1 billion aggregate principal amount of our 2.850% Series HH Notes due 2031 (the “Notes”). On March 5, 2021, we received net proceeds of approximately $1,089 million from the offering of the Notes, after deducting the underwriting discount and estimated expenses of the offering. We intend to use the net proceeds from this offering for general corporate purposes, including repayment of outstanding indebtedness, which may include amounts drawn under our Fifth Amended and Restated Credit Agreement with Bank of America, N.A., as administrative agent, and certain banks, dated as of June 28, 2019, as amended.

We will pay interest on the Notes on April 15 and October 15 of each year, commencing on October 15, 2021. The Notes will mature on April 15, 2031. We may redeem the Notes, in whole or in part, at our option, under the terms provided in the Form of Note.

We issued the Notes under an indenture dated as of November 16, 1998 with The Bank of New York Mellon, as successor to JPMorgan Chase Bank, N.A., formerly known as The Chase Manhattan Bank, as trustee (the “Indenture”) (which we previously filed as Exhibit 4.1 to our Annual Report on Form 10-K for the fiscal year ended January 1, 1999).

In connection with the public offering of the Notes, we filed a Prospectus dated February 18, 2021 and a Prospectus Supplement dated March 3, 2021 with the Securities and Exchange Commission, each of which forms a part of our Registration Statement on Form S-3 (Registration No. 333-253260) (the “Registration Statement”). We are filing the Underwriting Agreement, the Terms Agreement, the Indenture Officers’ Certificate pursuant to Section 301 of the Indenture, the Form of Note, and a legal opinion of our counsel, Gibson, Dunn & Crutcher LLP, on the Notes as exhibits to this report for the purpose of incorporating them as exhibits to the Registration Statement.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed with this report:



Underwriting Agreement General Terms and Provisions, dated March 3, 2021.

1.2    Terms Agreement, dated March 3, 2021, among Marriott International, Inc. and the Underwriters named therein.
4.1    Form of Note for the 2.850% Series HH Notes due 2031.
4.2    Indenture Officers’ Certificate (with respect to the 2.850% Series HH Notes due 2031) pursuant to Section 301 of the Indenture, dated March 5, 2021.
5.1    Opinion of Gibson, Dunn & Crutcher LLP, dated March 5, 2021.
23.1    Consent of Gibson, Dunn & Crutcher LLP (included in Exhibit 5.1 hereto).
104    The cover page to this Current Report on Form 8-K, formatted in inline XBRL.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: March 5, 2021     MARRIOTT INTERNATIONAL, INC.

/s/ Felitia Lee

      Felitia Lee
      Controller and Chief Accounting Officer